Phase 1/2 Trial Evaluating AOC 1044 in Healthy Volunteers and Participants with DMD Mutations Amenable to Exon 44 Skipping (DMD44): EXPLORE44 Trial Design (P4-8.007)

Mark Stahl,Elizabeth Ackermann, Yiming Zhu, Yvonne Tami, Steven Hughes, Chamindra Laverty,Craig McDonald

Neurology（2024）

Cited 0|Views6

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined